Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carnivora | 5 | 2024 | 28 | 1.930 |
Why?
|
Nephrology | 7 | 2023 | 270 | 1.640 |
Why?
|
Ecosystem | 6 | 2024 | 490 | 1.610 |
Why?
|
Conservation of Natural Resources | 8 | 2024 | 209 | 1.510 |
Why?
|
Kidney Transplantation | 15 | 2025 | 4278 | 1.400 |
Why?
|
Nephrotic Syndrome | 12 | 2024 | 381 | 1.380 |
Why?
|
Glomerulosclerosis, Focal Segmental | 6 | 2024 | 336 | 1.360 |
Why?
|
Hyperoxaluria, Primary | 2 | 2024 | 25 | 1.040 |
Why?
|
Renal Replacement Therapy | 11 | 2019 | 282 | 1.030 |
Why?
|
Kidney Failure, Chronic | 10 | 2021 | 2505 | 0.920 |
Why?
|
Peritoneal Dialysis | 4 | 2022 | 161 | 0.900 |
Why?
|
Canidae | 3 | 2014 | 4 | 0.880 |
Why?
|
Biodiversity | 4 | 2024 | 345 | 0.850 |
Why?
|
Leukopenia | 1 | 2023 | 213 | 0.840 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2024 | 125 | 0.830 |
Why?
|
Hyperoxaluria | 1 | 2022 | 33 | 0.820 |
Why?
|
Acute Kidney Injury | 10 | 2023 | 1946 | 0.800 |
Why?
|
Glomerulonephritis | 3 | 2019 | 333 | 0.780 |
Why?
|
Kidney Diseases | 8 | 2022 | 2101 | 0.770 |
Why?
|
Diarrhea | 2 | 2024 | 1317 | 0.710 |
Why?
|
Animals, Wild | 2 | 2023 | 78 | 0.710 |
Why?
|
Transplantation, Autologous | 1 | 2024 | 2127 | 0.650 |
Why?
|
Antilymphocyte Serum | 2 | 2023 | 492 | 0.640 |
Why?
|
Immunosuppressive Agents | 7 | 2024 | 4215 | 0.640 |
Why?
|
Hemofiltration | 3 | 2015 | 58 | 0.560 |
Why?
|
Renal Insufficiency, Chronic | 7 | 2023 | 2306 | 0.530 |
Why?
|
Renal Dialysis | 12 | 2024 | 1790 | 0.530 |
Why?
|
Urine | 2 | 2015 | 363 | 0.510 |
Why?
|
Catheters, Indwelling | 2 | 2018 | 436 | 0.510 |
Why?
|
Schistosoma haematobium | 1 | 2015 | 14 | 0.510 |
Why?
|
Catheter-Related Infections | 2 | 2021 | 279 | 0.510 |
Why?
|
Schistosomiasis haematobia | 1 | 2015 | 16 | 0.510 |
Why?
|
Recreation | 2 | 2015 | 124 | 0.510 |
Why?
|
Lions | 1 | 2014 | 3 | 0.470 |
Why?
|
Human Activities | 1 | 2014 | 26 | 0.460 |
Why?
|
Animals, Zoo | 1 | 2014 | 15 | 0.450 |
Why?
|
Child | 59 | 2025 | 80668 | 0.450 |
Why?
|
Hemolytic-Uremic Syndrome | 2 | 2009 | 105 | 0.450 |
Why?
|
Hematuria | 1 | 2015 | 232 | 0.450 |
Why?
|
Housing, Animal | 1 | 2014 | 47 | 0.440 |
Why?
|
Graft Rejection | 6 | 2023 | 4504 | 0.440 |
Why?
|
Pediatrics | 6 | 2021 | 3614 | 0.440 |
Why?
|
Kidney | 13 | 2023 | 7074 | 0.420 |
Why?
|
Urogenital Abnormalities | 3 | 2021 | 255 | 0.420 |
Why?
|
Virus Diseases | 1 | 2019 | 720 | 0.410 |
Why?
|
Urinary Tract | 4 | 2021 | 305 | 0.410 |
Why?
|
Blood Component Removal | 1 | 2013 | 124 | 0.390 |
Why?
|
Sexual Behavior, Animal | 2 | 2012 | 120 | 0.380 |
Why?
|
Body Size | 1 | 2014 | 461 | 0.370 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1103 | 0.370 |
Why?
|
Africa | 4 | 2024 | 726 | 0.360 |
Why?
|
Bacterial Infections | 1 | 2019 | 1390 | 0.350 |
Why?
|
Renal Insufficiency | 2 | 2022 | 811 | 0.350 |
Why?
|
Nephritis | 3 | 2023 | 146 | 0.330 |
Why?
|
Child, Preschool | 34 | 2025 | 42577 | 0.310 |
Why?
|
Levamisole | 1 | 2008 | 36 | 0.300 |
Why?
|
Child, Hospitalized | 2 | 2019 | 181 | 0.300 |
Why?
|
Sirolimus | 1 | 2014 | 1540 | 0.290 |
Why?
|
Adolescent | 42 | 2025 | 88904 | 0.280 |
Why?
|
BK Virus | 1 | 2008 | 120 | 0.280 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1794 | 0.280 |
Why?
|
Tuberous Sclerosis | 1 | 2014 | 1039 | 0.270 |
Why?
|
Polyomavirus Infections | 1 | 2008 | 193 | 0.250 |
Why?
|
Behavior, Animal | 1 | 2014 | 1865 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2060 | 0.250 |
Why?
|
Tumor Virus Infections | 1 | 2008 | 438 | 0.240 |
Why?
|
Plasmapheresis | 2 | 2023 | 205 | 0.240 |
Why?
|
Humans | 92 | 2025 | 766766 | 0.240 |
Why?
|
Acacia | 1 | 2004 | 2 | 0.230 |
Why?
|
Hypertension | 6 | 2025 | 8616 | 0.230 |
Why?
|
Germination | 1 | 2004 | 17 | 0.230 |
Why?
|
Antelopes | 1 | 2024 | 1 | 0.230 |
Why?
|
Review Literature as Topic | 1 | 2006 | 297 | 0.230 |
Why?
|
Fabaceae | 1 | 2004 | 103 | 0.220 |
Why?
|
Animals, Domestic | 1 | 2023 | 56 | 0.220 |
Why?
|
Pedigree | 7 | 2020 | 4539 | 0.220 |
Why?
|
Epispadias | 1 | 2023 | 19 | 0.220 |
Why?
|
Infant | 23 | 2020 | 36461 | 0.210 |
Why?
|
Animal Welfare | 3 | 2023 | 19 | 0.210 |
Why?
|
Citric Acid | 3 | 2013 | 124 | 0.210 |
Why?
|
Fires | 1 | 2004 | 170 | 0.200 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3927 | 0.200 |
Why?
|
Lymphoproliferative Disorders | 1 | 2006 | 527 | 0.200 |
Why?
|
Adjuvants, Immunologic | 1 | 2008 | 996 | 0.200 |
Why?
|
Recurrence | 3 | 2024 | 8507 | 0.200 |
Why?
|
Oxalates | 1 | 2022 | 99 | 0.200 |
Why?
|
Environment | 1 | 2008 | 1120 | 0.200 |
Why?
|
Maple Syrup Urine Disease | 1 | 2002 | 41 | 0.200 |
Why?
|
Bladder Exstrophy | 1 | 2023 | 107 | 0.200 |
Why?
|
Galactose | 2 | 2015 | 299 | 0.190 |
Why?
|
Femur Head Necrosis | 1 | 2022 | 133 | 0.190 |
Why?
|
Central Nervous System Diseases | 1 | 2006 | 518 | 0.190 |
Why?
|
Botswana | 2 | 2015 | 1057 | 0.190 |
Why?
|
Steroids | 3 | 2020 | 936 | 0.190 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 349 | 0.190 |
Why?
|
Nephrocalcinosis | 2 | 2017 | 51 | 0.190 |
Why?
|
Drug Resistance | 4 | 2019 | 1592 | 0.190 |
Why?
|
Vesico-Ureteral Reflux | 3 | 2021 | 433 | 0.180 |
Why?
|
Amniotic Fluid | 2 | 2001 | 381 | 0.180 |
Why?
|
Male | 48 | 2025 | 364142 | 0.180 |
Why?
|
Thrombosis | 1 | 2015 | 2953 | 0.180 |
Why?
|
Population Density | 3 | 2015 | 193 | 0.180 |
Why?
|
Lupus Nephritis | 1 | 2004 | 324 | 0.170 |
Why?
|
Virus Replication | 1 | 2008 | 2457 | 0.170 |
Why?
|
Consensus | 3 | 2023 | 3208 | 0.170 |
Why?
|
Creatinine | 3 | 2020 | 1917 | 0.160 |
Why?
|
Retrospective Studies | 19 | 2025 | 81635 | 0.160 |
Why?
|
Glycogen Storage Disease Type I | 2 | 2014 | 53 | 0.160 |
Why?
|
Animals | 23 | 2024 | 168930 | 0.160 |
Why?
|
Seasons | 2 | 2024 | 1521 | 0.160 |
Why?
|
Urethra | 1 | 2001 | 406 | 0.160 |
Why?
|
Glucocorticoids | 3 | 2019 | 2158 | 0.160 |
Why?
|
Female | 54 | 2025 | 396520 | 0.160 |
Why?
|
Infant, Newborn | 16 | 2022 | 26389 | 0.160 |
Why?
|
Water | 2 | 2024 | 1417 | 0.150 |
Why?
|
Peritonitis | 1 | 2021 | 368 | 0.150 |
Why?
|
Immunoglobulin A | 2 | 2023 | 992 | 0.150 |
Why?
|
Urinary Bladder | 2 | 2023 | 1155 | 0.150 |
Why?
|
Infusions, Intralesional | 1 | 2018 | 3 | 0.150 |
Why?
|
Nephrosis, Lipoid | 1 | 1998 | 46 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5690 | 0.150 |
Why?
|
Oligohydramnios | 1 | 2018 | 37 | 0.150 |
Why?
|
Poisoning | 1 | 2019 | 254 | 0.150 |
Why?
|
South Africa | 5 | 2015 | 1875 | 0.150 |
Why?
|
Glomerulonephritis, IGA | 1 | 1998 | 61 | 0.140 |
Why?
|
Hot Temperature | 1 | 2004 | 1442 | 0.140 |
Why?
|
Escherichia coli O157 | 1 | 1997 | 53 | 0.140 |
Why?
|
Nephritis, Interstitial | 1 | 1998 | 157 | 0.140 |
Why?
|
Hypertension, Renovascular | 1 | 1997 | 115 | 0.140 |
Why?
|
Quality Improvement | 4 | 2020 | 3850 | 0.140 |
Why?
|
Registries | 9 | 2025 | 8351 | 0.130 |
Why?
|
North America | 3 | 2025 | 1287 | 0.130 |
Why?
|
Amnion | 1 | 2018 | 204 | 0.130 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6307 | 0.130 |
Why?
|
Salmonella Infections | 1 | 1997 | 175 | 0.130 |
Why?
|
Nephrolithiasis | 1 | 2017 | 117 | 0.130 |
Why?
|
Age of Onset | 5 | 2019 | 3342 | 0.130 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 1998 | 297 | 0.130 |
Why?
|
Panthera | 1 | 2015 | 1 | 0.130 |
Why?
|
Treatment Outcome | 12 | 2024 | 65273 | 0.130 |
Why?
|
Catheterization, Central Venous | 2 | 2013 | 538 | 0.120 |
Why?
|
Population Dynamics | 2 | 2014 | 314 | 0.120 |
Why?
|
Marfan Syndrome | 1 | 1997 | 237 | 0.120 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 1995 | 41 | 0.120 |
Why?
|
Geography | 2 | 2014 | 651 | 0.120 |
Why?
|
Genetic Markers | 3 | 2017 | 2603 | 0.120 |
Why?
|
DNA Mutational Analysis | 3 | 2019 | 4114 | 0.120 |
Why?
|
Erythropoietin | 1 | 2019 | 718 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 508 | 0.120 |
Why?
|
Buffaloes | 1 | 2014 | 14 | 0.120 |
Why?
|
Predatory Behavior | 1 | 2014 | 26 | 0.120 |
Why?
|
Weight Gain | 1 | 2025 | 2356 | 0.120 |
Why?
|
Livestock | 1 | 2014 | 20 | 0.120 |
Why?
|
Mozambique | 1 | 2014 | 55 | 0.120 |
Why?
|
Colitis | 1 | 2023 | 1238 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 6 | 2019 | 18075 | 0.110 |
Why?
|
Patient Care | 1 | 2020 | 629 | 0.110 |
Why?
|
Neurofibromatoses | 1 | 2018 | 303 | 0.110 |
Why?
|
Biomass | 1 | 2014 | 135 | 0.110 |
Why?
|
Mutation | 7 | 2020 | 30213 | 0.110 |
Why?
|
Standard of Care | 1 | 2018 | 569 | 0.110 |
Why?
|
Fetal Diseases | 2 | 2018 | 915 | 0.110 |
Why?
|
Immunosorbent Techniques | 1 | 2013 | 174 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1627 | 0.110 |
Why?
|
Graft Survival | 4 | 2024 | 3904 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2019 | 1308 | 0.100 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 703 | 0.100 |
Why?
|
Social Dominance | 2 | 2012 | 39 | 0.100 |
Why?
|
Prospective Studies | 12 | 2023 | 54871 | 0.100 |
Why?
|
Tumor Lysis Syndrome | 1 | 2012 | 38 | 0.100 |
Why?
|
Inbreeding | 1 | 2012 | 48 | 0.100 |
Why?
|
Medication Therapy Management | 1 | 2013 | 131 | 0.100 |
Why?
|
Quality of Life | 4 | 2023 | 13476 | 0.100 |
Why?
|
Solutions | 1 | 2013 | 405 | 0.100 |
Why?
|
Environment Design | 1 | 2014 | 174 | 0.100 |
Why?
|
Urologic Diseases | 1 | 2014 | 246 | 0.100 |
Why?
|
Plasma Exchange | 1 | 2013 | 160 | 0.100 |
Why?
|
Pharmaceutical Services | 1 | 2013 | 145 | 0.100 |
Why?
|
Medication Reconciliation | 1 | 2013 | 153 | 0.090 |
Why?
|
Blood Volume | 1 | 2013 | 544 | 0.090 |
Why?
|
Ultrasonography | 3 | 2017 | 5992 | 0.090 |
Why?
|
Acute Disease | 2 | 2019 | 7241 | 0.090 |
Why?
|
Hypocalcemia | 1 | 2013 | 205 | 0.090 |
Why?
|
Hemoglobins | 1 | 1997 | 1531 | 0.090 |
Why?
|
Proteinuria | 3 | 2023 | 613 | 0.090 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1990 | 79 | 0.090 |
Why?
|
Cohort Studies | 9 | 2019 | 41710 | 0.090 |
Why?
|
Kidney Function Tests | 1 | 2012 | 685 | 0.090 |
Why?
|
Risk Factors | 9 | 2025 | 74881 | 0.090 |
Why?
|
Prednisone | 1 | 1995 | 1566 | 0.090 |
Why?
|
Remission Induction | 2 | 2024 | 2413 | 0.090 |
Why?
|
Metabolism, Inborn Errors | 1 | 2012 | 291 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2019 | 7868 | 0.090 |
Why?
|
Research Report | 1 | 2013 | 367 | 0.090 |
Why?
|
Anemia | 1 | 2019 | 1514 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2978 | 0.080 |
Why?
|
Young Adult | 10 | 2019 | 59939 | 0.080 |
Why?
|
Pharmacists | 2 | 2023 | 261 | 0.080 |
Why?
|
Extinction, Biological | 1 | 2009 | 30 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7431 | 0.080 |
Why?
|
Endangered Species | 2 | 2023 | 18 | 0.080 |
Why?
|
Incidence | 4 | 2018 | 21525 | 0.080 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2009 | 110 | 0.080 |
Why?
|
South America | 1 | 2009 | 180 | 0.080 |
Why?
|
Insulin | 2 | 2001 | 6608 | 0.080 |
Why?
|
Population Growth | 1 | 2008 | 50 | 0.080 |
Why?
|
Radiography | 3 | 2022 | 6968 | 0.070 |
Why?
|
Patient Care Team | 2 | 2016 | 2519 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39309 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2234 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3692 | 0.070 |
Why?
|
Genetic Association Studies | 4 | 2018 | 2746 | 0.070 |
Why?
|
Food Contamination | 1 | 2009 | 193 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4252 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2014 | 12985 | 0.070 |
Why?
|
Infant Formula | 1 | 2009 | 192 | 0.070 |
Why?
|
Asia | 1 | 2009 | 629 | 0.070 |
Why?
|
Heredity | 2 | 2017 | 149 | 0.070 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2232 | 0.070 |
Why?
|
Nutritional Support | 1 | 2008 | 178 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14652 | 0.070 |
Why?
|
Triazines | 1 | 2009 | 311 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3824 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 2971 | 0.070 |
Why?
|
United States | 11 | 2024 | 72951 | 0.070 |
Why?
|
Prevalence | 1 | 2023 | 15835 | 0.070 |
Why?
|
Nausea | 1 | 2009 | 681 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5753 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9404 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2023 | 4880 | 0.060 |
Why?
|
Self Report | 1 | 2017 | 3771 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2014 | 3561 | 0.060 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2023 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2270 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 949 | 0.060 |
Why?
|
Multiple Organ Failure | 2 | 2005 | 389 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4591 | 0.060 |
Why?
|
Antiporters | 2 | 2014 | 275 | 0.060 |
Why?
|
Models, Statistical | 2 | 2014 | 5091 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6820 | 0.060 |
Why?
|
Microtubules | 1 | 1990 | 1062 | 0.060 |
Why?
|
Viremia | 1 | 2008 | 727 | 0.060 |
Why?
|
Erythrocytes | 2 | 2013 | 2412 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2014 | 5306 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2885 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4087 | 0.060 |
Why?
|
Catheterization, Peripheral | 1 | 2007 | 346 | 0.060 |
Why?
|
Endosomes | 2 | 1997 | 521 | 0.060 |
Why?
|
Anticoagulants | 2 | 2013 | 4855 | 0.060 |
Why?
|
Disease Progression | 4 | 2023 | 13640 | 0.050 |
Why?
|
Membranes, Artificial | 1 | 2005 | 362 | 0.050 |
Why?
|
Dietary Proteins | 1 | 2008 | 960 | 0.050 |
Why?
|
Sclerosis | 1 | 2023 | 211 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9611 | 0.050 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 696 | 0.050 |
Why?
|
Algorithms | 3 | 2024 | 14072 | 0.050 |
Why?
|
Heterozygote | 3 | 2020 | 2795 | 0.050 |
Why?
|
Vertebrates | 1 | 2024 | 227 | 0.050 |
Why?
|
Plants | 1 | 2024 | 332 | 0.050 |
Why?
|
Area Under Curve | 2 | 2019 | 1638 | 0.050 |
Why?
|
Blood Chemical Analysis | 1 | 2004 | 434 | 0.050 |
Why?
|
Uremia | 1 | 2003 | 202 | 0.050 |
Why?
|
Europe | 1 | 2009 | 3430 | 0.050 |
Why?
|
Anxiety | 2 | 2017 | 4670 | 0.050 |
Why?
|
Agriculture | 1 | 2023 | 186 | 0.050 |
Why?
|
Sex Factors | 2 | 2024 | 10619 | 0.050 |
Why?
|
Biopsy | 2 | 2019 | 6779 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5368 | 0.050 |
Why?
|
Urinalysis | 1 | 2004 | 369 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9244 | 0.050 |
Why?
|
Infant Food | 1 | 2002 | 139 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2008 | 1469 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2006 | 1838 | 0.050 |
Why?
|
Headache | 1 | 2009 | 1260 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 1805 | 0.050 |
Why?
|
Adult | 18 | 2023 | 223307 | 0.050 |
Why?
|
Energy Intake | 1 | 2008 | 2142 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12150 | 0.040 |
Why?
|
Amphibian Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
Fetal Macrosomia | 1 | 2001 | 138 | 0.040 |
Why?
|
Species Specificity | 1 | 2024 | 2413 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 2 | 2001 | 737 | 0.040 |
Why?
|
Edema | 1 | 2004 | 764 | 0.040 |
Why?
|
Hospitals, Pediatric | 2 | 2019 | 1851 | 0.040 |
Why?
|
Prognosis | 5 | 2019 | 29948 | 0.040 |
Why?
|
Phenotype | 5 | 2018 | 16724 | 0.040 |
Why?
|
Glomerular Basement Membrane | 1 | 2019 | 35 | 0.040 |
Why?
|
Survival Rate | 5 | 2017 | 12825 | 0.040 |
Why?
|
Troponin | 1 | 2003 | 536 | 0.040 |
Why?
|
Risk Assessment | 5 | 2019 | 24295 | 0.040 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2002 | 267 | 0.040 |
Why?
|
Chickenpox | 1 | 2000 | 95 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1600 | 0.040 |
Why?
|
Exanthema | 1 | 2004 | 502 | 0.040 |
Why?
|
Acyclovir | 1 | 2000 | 266 | 0.040 |
Why?
|
Forms and Records Control | 1 | 2019 | 158 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2024 | 1186 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5514 | 0.040 |
Why?
|
Delphi Technique | 1 | 2023 | 892 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 2 | 2015 | 1885 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 168 | 0.040 |
Why?
|
Larva | 1 | 2020 | 511 | 0.040 |
Why?
|
Xenopus | 1 | 2020 | 710 | 0.040 |
Why?
|
Information Services | 1 | 2019 | 239 | 0.040 |
Why?
|
Mammals | 1 | 2024 | 1133 | 0.040 |
Why?
|
Reimbursement, Incentive | 1 | 2023 | 541 | 0.040 |
Why?
|
Acidosis, Renal Tubular | 1 | 1998 | 50 | 0.040 |
Why?
|
Shiga Toxin 2 | 1 | 1997 | 21 | 0.040 |
Why?
|
Shiga Toxin 1 | 1 | 1997 | 42 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1636 | 0.040 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 1998 | 150 | 0.040 |
Why?
|
Opossums | 1 | 1997 | 104 | 0.040 |
Why?
|
Cimetidine | 1 | 1997 | 76 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 684 | 0.040 |
Why?
|
Amoxicillin | 1 | 1998 | 179 | 0.040 |
Why?
|
Consanguinity | 1 | 2019 | 460 | 0.040 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1997 | 220 | 0.030 |
Why?
|
Lymphoma | 1 | 2006 | 1900 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2006 | 1594 | 0.030 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 1997 | 165 | 0.030 |
Why?
|
Enzyme Induction | 1 | 1997 | 455 | 0.030 |
Why?
|
Kidney Calculi | 1 | 2001 | 458 | 0.030 |
Why?
|
Seizures | 1 | 2009 | 2996 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2023 | 1895 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2020 | 22248 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2002 | 802 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1587 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2015 | 14762 | 0.030 |
Why?
|
Kidney Medulla | 1 | 1996 | 169 | 0.030 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2015 | 75 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10745 | 0.030 |
Why?
|
Dextrans | 1 | 1997 | 574 | 0.030 |
Why?
|
Genes, Dominant | 1 | 1998 | 855 | 0.030 |
Why?
|
Penicillins | 1 | 1998 | 404 | 0.030 |
Why?
|
Kidney Tubules, Proximal | 1 | 1997 | 386 | 0.030 |
Why?
|
Aquaporins | 1 | 1996 | 176 | 0.030 |
Why?
|
Actuarial Analysis | 1 | 1995 | 370 | 0.030 |
Why?
|
Odds Ratio | 2 | 2012 | 9661 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 2018 | 627 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2023 | 4860 | 0.030 |
Why?
|
Podocytes | 1 | 2019 | 404 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2014 | 71 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 223257 | 0.030 |
Why?
|
Empathy | 1 | 2019 | 474 | 0.030 |
Why?
|
Genes, Wilms Tumor | 1 | 2014 | 92 | 0.030 |
Why?
|
Homozygote | 1 | 2019 | 1775 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15563 | 0.030 |
Why?
|
Protein Binding | 2 | 2020 | 9320 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22350 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2025 | 15831 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2019 | 935 | 0.030 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 482 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 2020 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2274 | 0.030 |
Why?
|
Benchmarking | 1 | 2020 | 1056 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10100 | 0.030 |
Why?
|
Time | 1 | 2015 | 550 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2593 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2014 | 527 | 0.030 |
Why?
|
Hemodialysis Solutions | 1 | 2012 | 7 | 0.030 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2014 | 437 | 0.030 |
Why?
|
Endocytosis | 1 | 1997 | 951 | 0.030 |
Why?
|
Pregnancy | 4 | 2018 | 30237 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 1729 | 0.030 |
Why?
|
Epithelium | 1 | 1997 | 1606 | 0.030 |
Why?
|
Dogs | 2 | 2014 | 3834 | 0.020 |
Why?
|
Time Factors | 3 | 2007 | 40149 | 0.020 |
Why?
|
Gene Frequency | 1 | 2019 | 3624 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1134 | 0.020 |
Why?
|
Nitroglycerin | 1 | 1993 | 332 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2024 | 2416 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 1997 | 922 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3620 | 0.020 |
Why?
|
Cattle | 1 | 1997 | 3815 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3271 | 0.020 |
Why?
|
Genotype | 2 | 2017 | 13036 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2004 | 2160 | 0.020 |
Why?
|
Diabetes, Gestational | 1 | 2001 | 1263 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 1997 | 1477 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 3 | 1997 | 8106 | 0.020 |
Why?
|
Informed Consent | 1 | 2018 | 1010 | 0.020 |
Why?
|
Pain | 2 | 2017 | 5098 | 0.020 |
Why?
|
Ion Channels | 1 | 1996 | 1043 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15416 | 0.020 |
Why?
|
Alternaria | 1 | 1991 | 41 | 0.020 |
Why?
|
Lisinopril | 1 | 2011 | 60 | 0.020 |
Why?
|
Inappropriate Prescribing | 1 | 2013 | 212 | 0.020 |
Why?
|
Microtubule Proteins | 1 | 1990 | 61 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 1990 | 297 | 0.020 |
Why?
|
Polypharmacy | 1 | 2013 | 307 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6895 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3888 | 0.020 |
Why?
|
Heart Diseases | 1 | 2003 | 2817 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1555 | 0.020 |
Why?
|
Vascular Resistance | 1 | 1993 | 939 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1432 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1990 | 655 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 1 | 2018 | 1772 | 0.020 |
Why?
|
Family | 1 | 2020 | 3209 | 0.020 |
Why?
|
Losartan | 1 | 2011 | 263 | 0.020 |
Why?
|
Heptanoic Acids | 1 | 2011 | 344 | 0.020 |
Why?
|
Sports | 1 | 2015 | 701 | 0.020 |
Why?
|
Drug Interactions | 1 | 2013 | 1419 | 0.020 |
Why?
|
Adenosine Triphosphate | 2 | 1996 | 2001 | 0.020 |
Why?
|
Length of Stay | 1 | 2022 | 6490 | 0.020 |
Why?
|
Lysosomes | 1 | 1994 | 937 | 0.020 |
Why?
|
Cost Savings | 1 | 2013 | 902 | 0.020 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2011 | 428 | 0.020 |
Why?
|
Educational Measurement | 1 | 2015 | 1259 | 0.020 |
Why?
|
Calcium | 1 | 2001 | 5783 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 932 | 0.020 |
Why?
|
Reproduction | 1 | 2012 | 645 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2000 | 3070 | 0.020 |
Why?
|
Kinetics | 2 | 1996 | 6287 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1993 | 1602 | 0.020 |
Why?
|
Brain Chemistry | 1 | 1990 | 951 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2921 | 0.020 |
Why?
|
Cell Membrane | 1 | 1996 | 3641 | 0.020 |
Why?
|
Logistic Models | 1 | 2001 | 13278 | 0.020 |
Why?
|
Critical Illness | 2 | 2009 | 2750 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1512 | 0.020 |
Why?
|
Rats | 3 | 1997 | 23717 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9346 | 0.020 |
Why?
|
Muscles | 1 | 1990 | 1576 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3591 | 0.020 |
Why?
|
Drug Costs | 1 | 2013 | 1195 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15908 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3666 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14471 | 0.010 |
Why?
|
Pyrroles | 1 | 2011 | 1121 | 0.010 |
Why?
|
Rabbits | 1 | 1990 | 4752 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1514 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8066 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2011 | 970 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 2003 | 189 | 0.010 |
Why?
|
Polymers | 1 | 1990 | 1624 | 0.010 |
Why?
|
Allergens | 1 | 1991 | 1436 | 0.010 |
Why?
|
Creatine Kinase, MB Form | 1 | 2003 | 203 | 0.010 |
Why?
|
China | 1 | 2009 | 2383 | 0.010 |
Why?
|
Brain | 1 | 2009 | 27159 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81889 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1641 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10823 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 2005 | 538 | 0.010 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2008 | 1021 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2003 | 683 | 0.010 |
Why?
|
Amniocentesis | 1 | 2001 | 116 | 0.010 |
Why?
|
Swine | 1 | 1990 | 5987 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5536 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 2001 | 368 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6214 | 0.010 |
Why?
|
Luminescent Measurements | 1 | 2001 | 342 | 0.010 |
Why?
|
Karyotyping | 1 | 2001 | 1176 | 0.010 |
Why?
|
Automation | 1 | 2001 | 586 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5874 | 0.010 |
Why?
|
Isoenzymes | 1 | 2003 | 1688 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6259 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2003 | 1716 | 0.010 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 1998 | 103 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2003 | 1516 | 0.010 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2003 | 856 | 0.010 |
Why?
|
Depression | 1 | 2017 | 8228 | 0.010 |
Why?
|
Bicarbonates | 1 | 1998 | 293 | 0.010 |
Why?
|
Sulfates | 1 | 1998 | 380 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 6612 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1998 | 418 | 0.010 |
Why?
|
Aquaporin 6 | 1 | 1996 | 44 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12064 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10384 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 1998 | 784 | 0.010 |
Why?
|
Aquaporin 2 | 1 | 1996 | 125 | 0.010 |
Why?
|
Chlorides | 1 | 1998 | 666 | 0.010 |
Why?
|
Body Water | 1 | 1996 | 337 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1996 | 327 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 1996 | 568 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20708 | 0.010 |
Why?
|
Reference Values | 1 | 2001 | 4913 | 0.010 |
Why?
|
Molecular Weight | 1 | 1996 | 2168 | 0.010 |
Why?
|
Acids | 1 | 1994 | 125 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12534 | 0.010 |
Why?
|
Birth Weight | 1 | 2001 | 2123 | 0.010 |
Why?
|
Hemorrhage | 1 | 2005 | 3464 | 0.010 |
Why?
|
Electrolytes | 1 | 1994 | 279 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1998 | 2342 | 0.010 |
Why?
|
Gestational Age | 1 | 2001 | 3617 | 0.010 |
Why?
|
Serine | 1 | 1996 | 828 | 0.010 |
Why?
|
Asthma | 1 | 1991 | 6268 | 0.010 |
Why?
|
Permeability | 1 | 1994 | 721 | 0.010 |
Why?
|
Regression Analysis | 1 | 2001 | 6329 | 0.010 |
Why?
|
Haplotypes | 1 | 1998 | 2727 | 0.010 |
Why?
|
Antibodies, Fungal | 1 | 1991 | 33 | 0.010 |
Why?
|
Acetylcholine | 1 | 1993 | 628 | 0.010 |
Why?
|
Spores, Fungal | 1 | 1991 | 89 | 0.010 |
Why?
|
Echocardiography | 1 | 2003 | 5037 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1994 | 2551 | 0.010 |
Why?
|
Aged | 1 | 2023 | 171343 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1994 | 2478 | 0.000 |
Why?
|
Vasodilation | 1 | 1993 | 969 | 0.000 |
Why?
|
Skin Tests | 1 | 1991 | 630 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6507 | 0.000 |
Why?
|
Arteries | 1 | 1993 | 1123 | 0.000 |
Why?
|
Research Design | 1 | 2004 | 6207 | 0.000 |
Why?
|
Phosphoproteins | 1 | 1996 | 2448 | 0.000 |
Why?
|
Phosphorylation | 1 | 1996 | 8307 | 0.000 |
Why?
|
Immunoglobulin E | 1 | 1991 | 1495 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2001 | 20144 | 0.000 |
Why?
|
Hemodynamics | 1 | 1993 | 4188 | 0.000 |
Why?
|
Respiratory Insufficiency | 1 | 1991 | 1241 | 0.000 |
Why?
|
Heart Rate | 1 | 1993 | 4207 | 0.000 |
Why?
|
Blood Pressure | 1 | 1993 | 8533 | 0.000 |
Why?
|
Environmental Exposure | 1 | 1991 | 4554 | 0.000 |
Why?
|